6505--BUDESONIDE
ID: 36C77024Q0419Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/8f3a65c0d0dc49449d26d3ef91e39252/view
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for the procurement of Budesonide inhalation suspension, specifically for the National CMOP Office in Tucson, Arizona. This solicitation is set aside for small businesses, requiring the delivery of 6,776 cartons of Budesonide 0.5MG/2ML inhalation suspension, with each carton containing 30 ampules formatted for single-dose use. The procurement is critical for ensuring the availability of high-quality pharmaceutical supplies for veterans, adhering to strict compliance and safety standards, including the Drug Supply Chain Security Act. Interested vendors must submit their proposals by September 18, 2024, at 10 AM CDT, and can contact Contract Specialist Brigitte Kidder at Brigitte.Kidder@va.gov for further information.

    Point(s) of Contact
    Brigitte KidderContract Specialist
    Brigitte.Kidder@va.gov
    Files
    Title
    Posted
    36C77024Q0419_1.docx
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for the procurement of Budesonide, a pharmaceutical product, to replenish stock at the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). The solicitation number is 36C77024Q0419, with a response deadline set for September 18, 2024, at 10 AM Central Time. This notice emphasizes that the procurement falls under the Product Service Code 6505 (Drugs & Biologicals) and NAICS Code 325412 (Pharmaceutical Preparation Manufacturing). Small businesses are encouraged to submit proposals via email to the contracting officer, Brigitte Kidder. The solicitation package will be available for download on Contract Opportunities around September 11, 2024, and submissions must comply with the Drug Supply Chain Security Act, requiring pedigree information for all pharmaceuticals. The information provided in this notice is crucial for potential vendors to ensure they meet the VA's procurement requirements and timelines effectively.
    S02 PRICING SCHEDULE - 36C77024Q0419.xlsx
    The document outlines a federal Request for Proposal (RFP) related to a pharmaceutical procurement for the Veterans Affairs (VA) Consolidated Mail Outpatient Pharmacy (CMOP) in Tucson. The solicitation number is 36C77024Q0419. It specifies the request for Budesonide 0.5MG/2ML inhalation suspension, with a total quantity of 6,776 cartons required, each containing 30 ampules, formatted for single-dose use. The posting date for the solicitation is September 11, 2024, with a submission deadline of September 18, 2024, at 10 AM CDT. The document includes spaces for vendor identification, proposal details such as unit price and total price, as well as delivery scheduling comments. The focus is on ensuring timely delivery and compliance with the required specifications for pharmaceutical supplies to the VA healthcare system, reflecting the government's ongoing efforts to provide necessary medical supplies for veterans.
    S02 RFQ 36C77024Q0419.pdf
    The document is a Standard Form 1449 for a solicitation by the Department of Veterans Affairs to procure pharmaceuticals, specifically Budesonide inhalation suspension. It outlines details of the request for proposal (RFP), including contact information, eligibility criteria, proposal submission guidelines, and specific product requirements. The procurement is set aside for small businesses, with 100% of the contract designated for eligible small businesses. Key points include the requirement for delivery coordination, invoicing terms, and adherence to federal regulations such as the Drug Supply Chain Security Act. Vendors must ensure product labeling meets barcoding standards and submit documented compliance with quality and safety protocols. The document emphasizes that products offered must be directly from the original manufacturers with no gray market items allowed, along with guidance on handling recalls. Lastly, a comprehensive schedule of supplies and services, pricing information, delivery schedules, and contract clauses are included, ensuring both parties understand their obligations. This RFP indicates the agency's intent to ensure high-quality pharmaceutical supplies for veterans, reinforcing compliance, and safety standards.
    Lifecycle
    Title
    Type
    6505--BUDESONIDE
    Presolicitation
    6505--BUDESONIDE
    Currently viewing
    Solicitation
    Similar Opportunities
    6505--770-25-1-801-0021 -National CMOP DORZOLAMIDE/TIMOLOL -VA-25-00011267)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure DORZOLAMIDE/TIMOLOL ophthalmic solution for its Centralized Mail Order Pharmacy (CMOP) facilities. This procurement involves acquiring quantities ranging from 2,880 to 9,600 units of 10ML packaging, with a focus on ensuring compliance with the Drug Supply Chain Security Act and other regulatory standards. The pharmaceutical products are critical for providing necessary medical care to veterans, reflecting the VA's commitment to delivering high-quality healthcare solutions. Interested vendors must submit their quotations by November 12, 2024, following the release of the solicitation on November 4, 2024, and can direct inquiries to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    Q517--Staffing Service Tucson
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for staffing services at the Tucson Consolidated Mail Outpatient Pharmacy (CMOP), specifically targeting Service-Disabled Veteran-Owned Small Businesses (SDVOSBs). The contract requires the provision of pharmacists, pharmacy technicians, and shipper/packer personnel to support the processing of over 15 million prescriptions annually, with a minimum contract value of $4 million and a maximum of $250 million over five ordering periods from April 1, 2023, to March 31, 2028. This procurement is critical for maintaining efficient pharmaceutical operations and ensuring compliance with federal regulations, including HIPAA. Interested contractors must submit their proposals by the newly established deadline of July 23, 2024, and can direct inquiries to Contract Specialist Nicholas L. Schulte at nicholas.schulte1@va.gov.
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the supply of Norethindrone Acetate Tablets under Request for Proposal (RFP) 36E79724R0027. The procurement aims to establish contracts for the pharmaceutical product, with specific requirements regarding pricing for a base year and four option years, compliance with packaging standards, and adherence to the Drug Supply Chain Security Act (DSCSA) regulations. This medication is essential for various health treatments within the VA system, ensuring that veterans receive necessary pharmaceutical care. Interested contractors must submit their proposals by November 15, 2024, at 2:30 PM Central Standard Time, to the designated email addresses provided in the solicitation documents. For further inquiries, potential bidders can contact Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0005 to procure Abiraterone Acetate Tablets, an essential medication for various federal health care programs. The procurement aims to secure a reliable supply of 250mg Abiraterone Acetate Tablets, with an estimated annual requirement of 71,997 bottles, to support the VA, Department of Defense, Bureau of Prisons, and other federal entities. This contract will span one base year with four optional one-year extensions, ensuring continuity of supply for critical health services. Interested offerors should monitor sam.gov for the electronic issuance of the solicitation on or about November 22, 2024, with a closing date of December 6, 2024; inquiries can be directed to Richard Mahario at Richard.Mahario@va.gov or by phone at 708-786-5247.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Omeprazole Dr Capsules- NAC Repack
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) National Acquisition Center is preparing to issue a Request for Proposal (RFP) 36E79725R0002 for the procurement of Omeprazole DR Capsules, aimed at supporting various health service agencies, including the VA, Bureau of Prisons, and others. This unrestricted procurement will award one contract per group, with a total contract duration of one year and the potential for four additional one-year option periods. The procurement is critical for ensuring a reliable supply of essential medications, with specific packaging requirements including safety caps and unique NDC numbers for the products. Interested offerors should note that the solicitation is expected to be released electronically on or around November 19, 2024, with a closing date of December 3, 2024. For further inquiries, interested parties can contact Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852.
    6505--Aspirin_Dipyridamole SA Capsules (VA-25-00011491)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting offers for the procurement of Aspirin 25MG/Dipyridamole 200MG Sustained Action Capsules under solicitation number VA-25-00011491. This procurement aims to ensure a reliable supply chain for pharmaceuticals critical to various governmental health agencies, including the Department of Defense and Indian Health Services, and requires offerors to submit pricing for a base year and four option years, along with a Cost Recovery Fee of 0.5%. Compliance with the Drug Supply Chain Security Act (DSCSA) and FDA manufacturing standards is mandatory, and contractors must adhere to stringent packaging and labeling guidelines while demonstrating past performance evaluations. Interested parties should contact Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov for further details.
    Q517--Staffing Service MbM
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for staffing services under the Meds by Mail (MbM) program, specifically targeting Service-Disabled Veteran-Owned Small Businesses (SDVOSB). The procurement aims to provide licensed pharmacists and certified pharmacy technicians to support prescription processing across three facilities located in Cheyenne, WY; Dublin, GA; and Murfreesboro, TN. This initiative is crucial for enhancing healthcare services for veterans, ensuring efficient medication management and compliance with established protocols. Interested vendors must submit their proposals by the newly established deadline of August 6, 2024, with a total contract value estimated at $100 million over five years, including a minimum guarantee of $2 million. For further inquiries, potential bidders can contact Nicholas L. Schulte at nicholas.schulte1@va.gov or Christy Pendlay at Christy.Pendlay@va.gov.
    6505-- Pegfilgrastim
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Pegfilgrastim, a critical pharmaceutical product, through its Pharmaceutical Prime Vendor (PPV) program. The objective of this solicitation is to establish a reliable supply chain for specified medications at competitive prices, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and promoting small business participation. Pegfilgrastim is essential for patients undergoing chemotherapy, as it helps to stimulate the production of white blood cells, thereby reducing the risk of infection. Interested offerors must submit proposals that include unique National Drug Codes (NDCs), pricing for a base year and four optional renewal years, and details on compliance with safety standards. For further inquiries, contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0007 for the procurement of Warfarin Tablets, aimed at ensuring a reliable supply for various federal health agencies, including the Department of Defense and the Bureau of Prisons. This unrestricted procurement will cover multiple tablet strengths and packaging sizes, with an estimated annual usage detailed across 16 product types, and will be awarded for an initial one-year period with options for four additional years. The successful contractor must provide unique labeling and a National Drug Code (NDC) associated with their product, emphasizing the importance of compliance with federal regulations in pharmaceutical supply. Interested vendors should note that the solicitation will be electronically issued around November 13, 2024, with a response deadline of November 27, 2024; inquiries can be directed to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov.